Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
5-pentanoylamino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
5-[(Carbamoylcarbamoyl)amino]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
5-[2-(3-Chlorophenoxy)ethyl]-3-[(2R)-1-pyrrolidin-1-ylsulfonylpyrrolidin-2-yl]-1H-pyrazole
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
6-O-Caffeoylarbutin
Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020
6-O-desulfated enoxaparin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
6-O-desulfated unfranctionated heparin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
6-Thioguanosine 5'-diphosphate
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
6D3
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
7,4-di-O-galloyltricetifavan
Potential treatment - theoretical effect Natural product Antiviral Dec/02/2020
7-Bromo-3-[(7-bromo-4-hydroxy-2-oxo-1H-quinolin-3-yl)methyl]-4-hydroxy-1H-quinolin-2-one
Potential treatment - theoretical effect Experimental Antiviral Sep/14/2020
7-bromo-5-chloro-8-hydroxyquinoline
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
7-chloro-2-((3,5-dichlorophenyl)amino)quinazolin-4(3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
7-methyl-guanosine-5′-triphosphate-5′-guanosine
Potential treatment - theoretical effect Experimental Antiviral
8-(3-Chlorostyryl)caffeine
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
8-{3-hydroxy-4-[(7-hydroxynaphthalen-2-yl)oxy]phenoxy}-1,4-benzodioxin-5-ol
Potential treatment - theoretical effect Experimental Antiviral Apr/25/2021
89C8-ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/17/2020
9-hexadecenoic acid
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
A-1H4
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021